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Abstract. Purpose: Preserved thrombolysis in myocar-
dial infarction (TIMI) flow before percutaneous coronary
intervention (PCI) in acute myocardial infarction is related
to improved outcome. Gated single-photon emission
computed tomography (SPECT) allows the simultaneous
assessment of left ventricular perfusion and function. We
evaluated the initial risk area and subsequent evolution
of perfusion and function according to TIMI flow before
successful primary PCI. Methods: In 36 patients, treated
with abciximab, primary PCI and stenting, 99mTc-sestam-
ibi was injected before PCI and gated SPECT acquired
thereafter. Gated SPECT was repeated 7 and 30 days 
later. Perfusion defect, wall motion score index, left ven-
tricular ejection fraction and volumes were examined.
Results: Before PCI, 14 patients (group A) showed TIMI
flow 2–3 and 22 (group B) TIMI flow 0–1, but no differ-
ences in clinical variables, initial risk area, wall motion
score, ejection fraction or volumes. Perfusion defect was
smaller in group A at 7 (9%±11% vs 19%±14%, p<0.02)
and 30 days (7%±7% vs 16%±12%, p<0.02) and the 
salvage index was higher at 30 days (77%±22% vs
55%±28%, p<0.02). Wall motion score was lower in
group A at 30 days (p<0.05). Ejection fraction signifi-
cantly improved in both groups at 7 and 30 days. End-
diastolic volume showed a trend towards a reduction in
group A, whilst it was significantly increased in group B.
Conversely, end-systolic volume was significantly de-
creased in group A but remained unchanged in group B.
Conclusion: In the setting of optimal myocardial reper-
fusion for myocardial infarction, preserved TIMI flow
before PCI does not limit the initial risk area but it does
improve myocardial salvage and functional recovery.
Keywords: Abciximab – Angioplasty – Myocardial in-
farction – Scintigraphy
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Introduction
Myocardial salvage is the main mechanism by which 
patients with acute myocardial infarction benefit from
reperfusion therapy, either thrombolysis or primary per-
cutaneous coronary intervention (PCI), in terms of func-
tional recovery and clinical outcome. 99mTc-sestamibi
perfusion scintigraphy is considered a most reliable
method to detect myocardial salvage after reperfusion
therapy [1–5]. Nowadays, perfusion imaging is per-
formed using gated single-photon emission computed
tomography (SPECT), and thus allows the simultaneous
assessment of regional and global left ventricular func-
tion. This method represents a suitable tool to assess
changes over time in both myocardial perfusion and left
ventricular function in infarct patients [6–8]. Retrospec-
tive studies suggest that the presence of spontaneous an-
terograde flow before reperfusion therapy in acute myo-
cardial infarction improves left ventricular functional re-
covery and patient outcome [9–11]. Data from the early
1990s suggested that in the presence of preserved flow
before primary PCI there is a trend towards a smaller ini-
tial risk area, and myocardial salvage is significantly
greater [12]. Since then, major advances in primary PCI,
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including coronary stenting and glycoprotein IIb/IIIa re-
ceptor inhibitor (such as abciximab) administration, have
been introduced. The relationship between thrombolysis
in myocardial infarction (TIMI) flow before primary
PCI, extent of initial risk area, subsequent myocardial
salvage and functional recovery is not completely de-
fined in the setting of the currently used techniques [13].
In this study, we used gated SPECT to examine the
changes in myocardial perfusion and left ventricular
function after successful primary PCI, performed with
abciximab administration and coronary stenting, taking
into account the TIMI flow observed in the infarct-
related artery before mechanical revascularisation.
Materials and methods
Patient population
We prospectively evaluated 44 patients with first myocardial 
infarction referred to our catheterisation laboratory for primary 
angioplasty within 6 h of symptom onset, who received 99mTc-
sestamibi injection before mechanical recanalisation. Infarct diag-
nosis was based on typical chest pain lasting for >30 min associat-
ed with >0.1 mV ST segment elevation in at least two contiguous
electrocardiographic leads. Exclusion criteria were: (1) history of
previous myocardial infarction or other heart disease; (2) presence
of atrial fibrillation. The patient population was divided into two
groups according to the TIMI flow before primary angioplasty:
TIMI flow 2–3 (group A, n=15) and TIMI flow 0–1 (group B,
n=29). Eight patients were excluded from the analysis for the fol-
lowing reasons: clinical instability precluding the acquisition of
myocardial scintigraphy at admission (n=3 of group B); subopti-
mal mechanical recanalisation with TIMI flow 2 after primary 
angioplasty (n=1 of group A and n=3 of group B); incomplete
scintigraphic data (n=1 of group B; patient died before 30 days’
evaluation). Thus, the final study group included 36 patients who
underwent successful primary PCI.
Study protocol
At admission, all patients received aspirin (500 mg), heparin 
(bolus of 60 U/kg body weight, up to a maximum of 5,000 U, fol-
lowed by a continuous infusion of 7 U/kg per hour), clopidogrel
(300 mg) and abciximab (bolus of 0.25 mg/kg body weight fol-
lowed by a continuous infusion of 0.125 µg/kg per minute, up 
to a maximum of 10 µg/min, for 12 h). Then, patients were trans-
ferred to the catheterisation laboratory, where 99mTc-sestamibi
[1,110 MBq (30 mCi)] was injected. Immediately after tracer in-
jection, patients underwent selective coronary angiography and
primary PCI. Gated SPECT was acquired within 6 h of tracer 
injection to assess the extent and severity of the initial perfusion
defect, wall motion score, left ventricular ejection fraction and
volumes. Subsequently, patients underwent baseline resting gated
SPECT at 7 and 30 days of index infarction to assess the changes
in the extent and severity of myocardial perfusion defect, left ven-
tricular wall motion, ejection fraction and volumes. All patients
gave informed consent to participation in the study, which was 
approved by the Ethics Committee of our institutions.
Coronary angiography and mechanical revascularisation
Selective coronary angiography was performed in multiple projec-
tions before mechanical reperfusion. Immediately after diagnostic
angiography, PCI was performed using standard material. The
TIMI flow in the infarct-related vessel before and after coronary
angioplasty was graded visually by consensus of two blinded 
experienced angiographers. TIMI grade 3 coronary flow in the
treated vessel with a residual stenosis <20% was considered 
indicative of successful angioplasty [14].
Gated SPECT
Scintigraphic images were acquired using a dual-head gamma 
camera (ADAC Vertex, Milpitas, CA, USA) equipped with high-
resolution collimators and with a 15% window centred on the 
140-keV photopeak of 99mTc. SPECT was performed in step-and-
shoot mode, with 32 projections over a 180° elliptical orbit, matrix
size 64×64, 45 s/projection, 8 frames/cardiac cycle. The studies
were reconstructed using filtered back-projection without attenua-
tion or scatter correction and realigned along the heart axis. The left
ventricle was divided into 16 segments [15]. Regional wall motion
was assessed visually by consensus of two blinded experienced ob-
servers and scored using a four-point scale (1=normal, 2=hypokine-
sis; 3=akinesis; 4=dyskinesis) [16]. Previous data indicated a good
reproducibility of these evaluations in our laboratory [17]. Segments
that showed tracer uptake less than 30% of peak uptake were
deemed unsuitable for regional functional analysis and were consid-
ered by definition to be akinetic [18]. The left ventricular wall mo-
tion score index was calculated as the sum of the single segment
scores divided by 16. Segment functional recovery after revasculari-
sation was defined on the basis of a decrease by ≥1 grade in wall
motion score at follow-up [16]. However, a change from dyskinesia
to akinesia was not considered to be significant [19]. Gated SPECT
processing and calculation of ejection fraction were performed by
an automated and validated method [6]. Perfusion defect extent was
assessed on the polar map displays using a threshold method and
expressed as percentage of the left ventricular wall [4, 5, 8]. The
following parameters were calculated: the initial perfusion defect
(area at risk) and the infarct size at 7 and at 30 days. The difference
between area at risk and infarct size provided the extent of myocar-
dial salvage. The salvage index was calculated as the ratio between
myocardial salvage and area at risk [4, 5].
Statistical analysis
Results are expressed as mean ± standard deviation. The compar-
isons within groups were made with the Wilcoxon paired rank test
or the Friedman non-parametric analysis of variance (ANOVA), as
appropriate. The comparisons between groups were made with the
Mann-Whitney U test. The comparison of proportions was made
using Fisher’s exact test. The correlations between ejection fraction
and perfusion defect were calculated using Pearson’s correlation
coefficient. A p value <0.05 was considered statistically signifi-
cant. Statistical analysis was performed using the STATISTICA 4.5
software program.
Results
Before PCI, 14 patients (group A) showed a TIMI flow
of >1 in the infarct-related vessel (TIMI flow 3 in nine
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and TIMI flow 2 in five) while 22 patients (group B) 
had no anterograde flow. There were no significant dif-
ferences in baseline clinical and angiographic findings
between the two groups (Table 1). Group A showed a
higher degree of ST segment elevation resolution at
60 min of recanalisation (84%±26% vs 64%±25%,
p<0.02) and a lower creatine kinase peak (1,413±1,260
vs 2,859±2,042 IU, p<0.03). At the time of the 30-day
follow-up, no patient had evidence of re-infarction,
stress-induced ischaemia (stress gated SPECT was per-
formed in 25 patients) or restenosis of the culprit vessel
(control angiography was performed in the remaining 11
patients).
Myocardial perfusion imaging
The area at risk ranged from 8% to 50% in group A
(28%±14%) and from 11% to 59% in group B
(33%±14%), and was not significantly different between
the two groups (Table 2). The salvage index was clearly
higher in group A at 7 days, and the difference became
significant (p<0.02) at 30 days. Therefore, in spite of a
similar trend towards a significant decrease in perfusion
defect in the two groups (ANOVA chi-square 22.3,
p<0.00001 and 38.9, p<0.000001, respectively, in groups
A and B), the infarct size was smaller in group A pa-
tients at 7 days (9%±11% vs 19%±14%, p<0.02) and at
30 days (7%±7% vs 16%±12%, p<0.02) (Fig. 1).
Left ventricular function
In the admission gated SPECT, the infarct zone included
89 asynergic segments out of 224 in group A and 147
out of 352 in group B (NS), without a significant differ-
ence in the wall motion score index of the infarct zone
between the two groups. At 7 days, functional recovery
was observed in 52/89 (58%) asynergic segments in
group A and in 49/147 (33%) in group B (p<0.0005).
Also, the proportion of segmental functional recovery at
30 days was higher in group A than in group B (78% vs
71%), but the difference was not statistically significant.
The wall motion score index improved significantly in
both groups (ANOVA chi-square 25, p<0.000001 and
31, p<0.000001, respectively, in groups A and B), but
was significantly lower in group A at 30 days (p<0.05)
(Table 3). Significant correlations were found between
Table 1. Comparison of clini-
cal and angiographic character-
istics between patients with
(group A) and patients without
(group B) anterograde flow of
the infarct-related vessel before
primary PCI
Group A (n=14) Group B (n=22) p value
Mean age (yr) 64±12 62±11 NS
Men (n, %) 13 (93) 16 (73) NS
Hypertension (n, %) 6 (43) 7 (32) NS
Diabetes mellitus (n, %) 2 (14) 5 (23) NS
Hypercholesterolaemia (n, %) 5 (36) 11 (50) NS
Current smoker (n, %) 9 (64) 10 (45) NS
Time from symptom onset to:
Admission (min) 152±106 138±109 NS
Mechanical reperfusion (min) 227±108 211±118 NS
Multivessel disease (n, %) 5 (36) 10 (45) NS
Myocardial infarct territory (n, %)
Left anterior descending artery 7 (50) 6 (27) NS
Left circumflex artery 1 (7) 4 (18) NS
Right coronary artery 6 (43) 12 (55) NS
Coronary stenting (n, %) 14 (100) 22 (100) NS
Fig. 1. Histogram showing the perfusion defect expressed in per-
cent of left ventricular wall at admission (initial risk area before
PCI = baseline) and during follow-up. Patients with preserved
TIMI flow before PCI (group A) are indicated by white bars, and
those without (group B) by black bars
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risk area and ejection fraction at admission (r=−0.72;
p<0.00001) and between infarct size and ejection frac-
tion at 7 (r=−0.53, p<0.001) and 30 days (r=−0.50;
p<0.003). An improvement in ejection fraction was 
observed in both groups (ANOVA chi-square 26.1,
p<0.000001 and 20.5, p<0.00005, respectively, in groups
A and B; Fig. 2). As regards LV volumes, the end-
diastolic volume decreased from admission to 30 days in
group A, but the change was not significant; in contrast,
there was a significant increase in end-diastolic volume
in group B (ANOVA chi-square 8.7, p<0.02; Fig. 3). The
end-systolic volume decreased significantly in group A
(ANOVA chi-square 11.6, p<0.005), but remained un-
changed in group B (Fig. 4).
Discussion
Retrospective studies have shown that in acute myocar-
dial infarction, spontaneous anterograde flow (TIMI
Table 2. Comparison of perfusion data between patients with (group A) and patients without (group B) anterograde flow of the infarct-
related vessel before primary PCI
Patients Risk area Defect at 7 days Defect at 30 days Salvage index Salvage index 
(%) (%) (%) at 7 days at 30 days
Group A
1 26 1 1 0.96 0.96
2 24 1 2 0.96 0.96
3 18 1 4 0.94 0.78
4 48 22 14 0.54 0.71
5 50 26 23 0.48 0.54
6 16 16 9 0 0.44
7 39 1 1 0.97 0.97
8 12 1 2 0.91 0.83
9 23 6 4 0.74 0.83
10 13 9 8 0.31 0.38
11 38 9 2 0.76 0.95
12 29 1 1 0.97 0.97
13 41 32 21 0.22 0.49
14 8 0 0 0.38 1
Mean±SD 28±14 9±11* 7±7** 65±33 77±22***
Group B
15 33 11 11 0.67 0.67
16 19 0 0 1 1
17 11 3 3 0.73 0.73
18 43 12 3 0.72 0.93
19 30 25 23 0.16 0.23
20 28 9 5 0.68 0.82
21 43 21 15 0.51 0.65
22 59 46 33 0.22 0.44
23 28 11 8 0.61 0.71
24 44 23 19 0.48 0.57
25 24 12 6 0.50 0.75
26 19 12 12 0.37 0.37
27 22 5 5 0.77 0.77
28 45 25 23 0.44 0.49
29 24 17 21 0.30 0.13
30 27 26 20 0.37 0.26
31 40 26 10 0.35 0.75
32 20 18 18 0.10 0.10
33 21 6 2 0.71 0.91
34 58 56 44 0.03 0.20
35 57 33 38 0.42 0.32
36 38 28 26 0.26 0.31
Mean±SD 33±14 19±14* 16±12** 47±25 55±28***
*p<0.02; **p<0.02; ***p<0.02
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flow >1) before reperfusion therapy improves left ven-
tricular function recovery and patient outcome [9–11].
However, the exact mechanisms that mediate this
favourable effect are still uncertain. In the early 1990s,
Clements et al. demonstrated that a preserved TIMI
flow (grade 1–3) was related to a smaller initial risk
area and to a greater effectiveness of primary PCI in
terms of myocardial salvage and limitation of the final
infarct size [12]. In that study, a TIMI grade 2 or 3 
was present in just 9/60 patients (15%). In our series, a
TIMI grade 2 or 3 was observed in 15/43 patients
(35%), possibly because of the adjunctive pharmacolog-
ical treatment with abciximab, as demonstrated in the
ADMIRAL study [20]. Accordingly, we used a more de-
manding definition of preserved flow, including grades
2 and 3 only. In this setting, the area at risk was not sig-
nificantly smaller in patients with versus those without
preserved anterograde flow at admission. On the other
hand, the salvage index was significantly higher in 
patients with TIMI flow >1 before primary PCI, who
also had a significantly smaller infarct size at 30 days. 
It could be concluded that preserved flow plays a
favourable role in obtaining more extensive myocardial
salvage. The more effective myocardial reperfusion was
also documented by the significantly earlier ST segment
elevation resolution and by the lower creatine kinase
peak observed in patients with anterograde flow before
PCI. These findings are in agreement with those of other
recent studies, which, using different methods, verified
myocardial reperfusion in infarct patients treated with
primary PCI [14, 21].
As expected, the reduction in the perfusion defect was
followed by the functional recovery of the infarct zone,
which we could evaluate directly from perfusion imag-
ing using gated SPECT. The use of gated SPECT to 
assess left ventricular function from perfusion data is the
innovative methodological contribution of this study. Al-
though area at risk and final infarct size are considered
reliable surrogate end-points for studies comparing dif-
ferent treatment strategies in acute myocardial infarction
[22], the prognostic implications of left ventricular ejec-
tion fraction and left ventricular volumes are well known
[23–25]. Gated SPECT could be particularly advanta-
geous for this kind of study, given that it allows repro-
ducible assessment of both perfusion and functional
changes [2–5, 16, 17, 26]. To our knowledge, this is one
of the first studies to consider the value of repeated per-
fusion scans in the setting of acute myocardial infarction
in conjunction with the additional contribution of repeat-
ed measurements of the left ventricular ejection fraction.
According to our data, a trend towards improvement
in left ventricular function was observed in both groups,
but the single parameter that became significantly differ-
ent between the two groups was the wall motion score
index, which was significantly lower in group A than in
group B at 30 days. However, the analysis of left ventric-
ular volume changes showed that in group A there was a
Fig. 2. Left ventricular ejection fraction at admission (= baseline)
and during follow-up. Same symbols as in Fig. 1
Fig. 3. Left ventricular end-diastolic volume (EDV) at admission
(= baseline) and during follow-up. Same symbols as in Fig. 1
Fig. 4. Left ventricular end-systolic volume (ESV) at admission 
(= baseline) and during follow-up. Same symbols as in Fig. 1
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trend towards a decrease in both the end-diastolic and
the end-systolic volume, which reached statistical signif-
icance for the latter parameter. Conversely, in group B
there was a significant increase in end-diastolic volume
from admission to 30-day follow up, whilst the end-
systolic volume remained unchanged. Therefore, whilst
group A had a favourable volumetric evolution, group B
showed a trend to left ventricular remodelling.
The results of this study must be evaluated with cau-
tion because of its limitations. As already mentioned, the
small patient population is a most important limitation.
This also prevented analysis of possible differences 
related to the TIMI grade in cases of preserved flow. 
Ideally, patients with TIMI grade 2 should be examined
separately from those with grade 3. Unfortunately, the
number of group A patients was too small to allow such
Table 3. Comparison of functional data between patients with (group A) and patients without (group B) anterograde flow of the infarct-
related vessel before primary PCI
Patients WMSI LVEF (%) LVEDV (ml) LVESV (ml)
Adm 7 days 30 days Adm 7 days 30 days Adm 7 days 30 days Adm 7 days 30 days
Group A
1 2 1 1 40 58 58 80 105 116 48 44 48
2 1.68 1.31 1.06 54 65 68 73 86 94 33 31 35
3 1.56 1.12 1 42 44 52 142 159 75 82 90 32
4 2.37 1.43 1.43 32 42 48 144 119 72 98 69 38
5 2.37 2.06 2.12 25 42 43 189 174 186 142 101 106
6 1.37 1.31 1.25 46 47 52 93 93 60 50 49 29
7 2 1.93 1 44 46 55 95 83 86 51 45 39
8 1.25 1.06 1.06 51 55 55 120 114 71 56 52 32
9 1.5 1.43 1 40 42 67 96 116 89 57 67 40
10 1.43 1.37 1.12 35 39 42 142 149 124 91 91 72
11 1.93 1.31 1.12 26 29 39 285 255 108 210 210 65
12 1.18 1.06 1.06 49 62 62 66 51 52 34 19 20
13 2.31 2.06 1.93 36 39 44 167 137 73 107 83 41
14 1.25 1 1 53 53 58 76 126 115 36 59 49
Mean±SD 1.7±0.4 1.4±0.4 1.2±0.4* 41±9 47±10 53±9 126±19 126±49 94±34 79±50 70±40 45±23
Group B
15 1.44 1.19 1 30 52 54 118 60 46 83 32 22
16 1.12 1 1 53 35 54 88 88 88 42 42 32
17 1.37 1.37 1.12 48 51 48 74 80 120 39 34 55
18 1.75 1.12 1.12 33 60 65 107 81 102 71 53 47
19 1.75 1.75 1.75 50 56 57 140 139 163 67 65 84
20 1.37 1.25 1.12 47 43 63 77 106 111 41 35 38
21 2.25 1.62 1.18 45 52 55 110 100 98 57 34 42
22 2.25 2.18 1.62 36 43 52 62 85 74 40 49 27
23 1.5 1.5 1.12 49 63 60 45 42 45 23 20 20
24 2 1.87 1.62 39 53 51 97 107 120 60 61 58
25 1.43 1.5 1.43 54 49 49 69 63 77 31 23 31
26 1.37 1.25 1.06 49 51 50 135 136 169 75 65 83
27 1.87 1.37 1.18 39 50 47 117 114 118 71 58 60
28 1.75 1.62 1.25 35 44 44 137 89 90 75 43 42
29 1.43 1.43 1.43 40 46 48 96 115 132 57 53 70
30 1.37 1.37 1.25 42 45 44 114 103 111 66 58 62
31 1.93 1.37 1.5 33 45 43 89 101 128 59 54 67
32 1.43 1.43 1.31 45 29 34 95 88 107 47 41 60
33 1.37 1.37 1.12 46 24 29 74 96 76 39 53 44
34 2.68 2.43 2 21 43 59 175 215 216 138 153 143
35 2.75 2.75 1.56 23 52 54 225 213 250 173 162 177
36 2.06 2 1.68 39 35 54 111 111 108 68 60 44
Mean±SD 1.7±0.4 1.6±0.4 1.3±0.3* 41±9 47±9 50±9 107±41 106±41 115±49 65±35 58±34 60±37
Adm, admission; LV, left ventricle; EF, ejection fraction; EDV, end-diastolic volume; ESV, end-systolic volume; WMSI, wall motion
score index
*p<0.05
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a separate evaluation. Similarly, we had no control group
of patients who had not been submitted to revascularisa-
tion, and thus we were unable to delineate the natural
history of an acute myocardial infarction as assessed by
repeated gated SPECT studies. However, a large number
of studies have already demonstrated the effectiveness of
primary PCI in patients admitted early after symptom
onset, and thus ethical considerations precluded denial of
this treatment just to evaluate the natural course of gated
SPECT changes. No prognostic data were available in
our series and therefore we were unable to establish
whether the higher degree of myocardial salvage and the
better recovery of the patients with preserved flow be-
fore primary PCI also implied a more favourable clinical
outcome. Naturally, the general limitations of gated
SPECT for the evaluation of left ventricular function
must be considered [27]. The inverse relationship be-
tween infarct size and left ventricular ejection fraction
on the basis of a single gated SPECT study has recently
been demonstrated, but not in the setting of acute myo-
cardial infarction [28]. It must also be considered that
the admission ejection fraction was measured after PCI
and therefore some degree of very early improvement
could already have been present (although this is quite
unlikely), and might have affected the relationship with
the perfusion defect size that was present at the time of
tracer injection. Furthermore, an influence of myocardial
stunning or subendocardial ischaemia in producing an
apparent decrease in tracer uptake through the partial
volume effect cannot be excluded [29]. It must be 
borne in mind, however, that gated SPECT was always
acquired after a resting injection in our series, and that
other data suggest that gating does not have a major in-
fluence on the infarct size assessment [30]. Finally, the
difficulty in defining the regional wall motion by gated
SPECT in segments with very low tracer uptake must be
considered, although prior data suggest that it is very un-
likely that these segments will include a significant
amount of viable tissue and hence have a preserved wall
motion [18].
In conclusion, our data, obtained using a single imag-
ing modality, i.e. perfusion gated SPECT, suggest that in
the setting of optimal myocardial reperfusion, preserved
anterograde flow before primary PCI plays a favourable
role in terms of myocardial salvage. Moreover, we ob-
served a more favourable trend towards left ventricular
ejection fraction increase and left ventricular volume de-
crease in patients with preserved TIMI flow compared
with the other patients. Further studies on wider patient
populations are needed to confirm these preliminary 
observations and to analyse fully their clinical and prog-
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